Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$17.79 - $30.86 $7.22 Million - $12.5 Million
405,751 New
405,751 $7.5 Million
Q2 2022

Aug 03, 2022

SELL
$13.01 - $27.22 $3 Million - $6.27 Million
-230,417 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$20.94 - $27.5 $945,294 - $1.24 Million
-45,143 Reduced 16.38%
230,417 $5.58 Million
Q2 2021

Jul 20, 2021

SELL
$19.4 - $27.42 $452,563 - $639,653
-23,328 Reduced 7.8%
275,560 $6.72 Million
Q4 2020

Jan 22, 2021

SELL
$41.04 - $56.79 $414,996 - $574,260
-10,112 Reduced 3.27%
298,888 $16 Million
Q3 2020

Oct 19, 2020

BUY
$36.42 - $57.0 $2.55 Million - $3.99 Million
70,000 Added 29.29%
309,000 $12.7 Million
Q2 2020

Jul 23, 2020

BUY
$39.26 - $52.73 $6.24 Million - $8.38 Million
159,000 Added 198.75%
239,000 $11.6 Million
Q4 2019

Jan 21, 2020

BUY
$36.21 - $51.4 $2.9 Million - $4.11 Million
80,000 New
80,000 $3,000
Q1 2019

May 02, 2019

SELL
$16.17 - $27.38 $2.81 Million - $4.76 Million
-173,700 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$14.32 - $22.92 $544,160 - $870,960
38,000 Added 28.0%
173,700 $2.81 Million
Q3 2018

Nov 07, 2018

BUY
$13.03 - $21.81 $48,211 - $80,697
3,700 Added 2.8%
135,700 $2.82 Million
Q2 2018

Aug 14, 2018

BUY
$15.07 - $22.34 $828,850 - $1.23 Million
55,000 Added 71.43%
132,000 $2.02 Million
Q3 2017

Nov 03, 2017

BUY
$29.49 - $38.37 $2.27 Million - $2.95 Million
77,000
77,000 $2.9 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.